Atlas Trials

Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults

Clinical trial NCT04950751 · WITHDRAWN

Trial details

NCT number
NCT04950751
Sponsor
Clover Biopharmaceuticals AUS Pty
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-08-01
Primary completion
2022-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.